Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).
about
Moving beyond Karnofsky and ECOG Performance Status Assessments with New TechnologiesMultiple myeloma in the very elderly patient: challenges and solutionsChemotherapy in Elderly Patients with Gastric CancerRole of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgeryManagement of locally advanced and metastatic colon cancer in elderly patientsAdjuvant treatment for older women with invasive breast cancerTreatment of Elderly Patients with Squamous Cell Carcinoma of the Head and NeckPhysical performance measures for predicting outcome in cancer patients: a systematic review.The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance.First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II studyRandomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial.Geriatric considerations in the treatment of advanced prostate cancerOlder breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up.Is it time for comprehensive geriatric assessment to move beyond primary care? The case for targeting medical sub-specialty practiceRadiation therapy for older patients with brain tumorsImpact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: protocol for a multicentre randomised controlled trial (EGeSOR)The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Frailty in elderly peopleGeriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.Geriatric oncology: an overview of progresses and challenges.Older women's experience with breast cancer treatment decisionsComorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer.Study protocol of KLIMOP: a cohort study on the wellbeing of older cancer patients in Belgium and the Netherlands.Geriatric oncology: The need for a separate subspecialty.Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment.How to implement a geriatric assessment in your clinical practiceExclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.Use of geriatric assessment for older adults in the oncology setting: a systematic review.Bladder cancer in the elderly.Geriatric oncology: comparing health related quality of life in head and neck cancer patients.Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.The impact of low-grade toxicity in older people with cancer undergoing chemotherapyGeriatric assessment in surgical oncology: a systematic review.Which frail older patients use online health communities and why? A mixed methods process evaluation of use of the Health and Welfare portal.Management of complications of androgen deprivation therapy in the older man.Association of cancer with geriatric syndromes in older Medicare beneficiariesImplementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401Bevacizumab treatment in the elderly patient with metastatic colorectal cancer.The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients.
P2860
Q26749492-37EBA4C3-1687-4D74-B10C-1B97A8C4DB29Q26752991-BB15ACA0-E2B5-4B61-83EC-B828EB42D16CQ26771424-1413BECB-3C1D-40A2-9C93-62AC40AF0969Q26827248-80D980FD-28C5-46BB-9CEC-FDAAA79E527EQ27026129-F58BC259-6776-42CF-8E0F-A96BDECA304BQ28066744-23860296-19F4-41A5-A6EC-C896F48A624FQ28076894-7EB2A7E2-5AC3-4642-993B-7B91F52D4030Q30244765-1782764E-0463-4102-8386-B87B09A9B72CQ30585699-5129CE2D-57F2-48E7-B050-E1F3F2349727Q33378383-2DF924EE-27D1-4E35-9A41-DFECF1084A1AQ33398722-E7309609-C767-4F9E-A6D7-EE898A0F51F1Q33556256-9B5CAF22-2A99-4ABE-A828-BC17981F3D9CQ33598327-04FB7DF1-83A2-4619-A8F0-B725882AE3F9Q33627703-8F79B6BF-31A2-4AF5-8A31-7E48A66A7241Q33767995-E25E7F5B-7F22-4C5F-B71E-96FC31C3E087Q33815025-CCC64BFC-4D86-499D-856E-83F0ACC6FA7EQ33844620-975F4DED-2C6D-4520-8011-9E6C4C7908BCQ33865329-F3C160B3-9D0E-48FE-BF8C-860D78A18797Q33902569-4533EC36-D940-46F2-BC0E-743DAED90E3AQ33978945-8785BC26-1A85-4C29-BB4D-2984B38D206DQ33979972-CB839A06-FE69-4FBA-9324-97DD5AF1B448Q33980622-27510C20-C0A0-430F-A8EC-411049D25D1FQ33997290-7B59B21C-E38D-4FEC-AC80-88B2E8DDD97FQ34057429-355D0940-8E6C-4A95-B0FF-8C0813DC5AEBQ34300407-7371C7F4-7DEE-4EEB-8472-561390745535Q34306560-3B8259B9-6D92-4BE3-B0C9-FA5B193A10D6Q34359304-43FDAC85-EF5B-43C1-AEBB-51DF68BC2572Q34359352-A5A7A844-4C82-4071-9E69-7555464F20CFQ34360763-F07D7016-A341-4B10-BAC1-661997F19FE2Q34479053-88C96D98-FEC9-4DAA-BEED-B9DE5A69DD10Q34547468-B7EA245B-B3F5-4331-86CC-714BC75BB7FCQ34682115-33F778A2-8335-48EB-B42A-F7A4643655DDQ34686967-6946F9E2-52B8-4238-A2CE-48D972D40597Q34713833-36F1524A-9D7C-4E94-8F0C-FD339E32D1E3Q34766361-1C172170-4A07-4335-AB2F-1FB9994B6F06Q34782101-58F8A854-B26E-4B50-9308-29B314A1A3D2Q34866406-E277DEBA-D3CA-47BF-9E46-EC5E7FE7503BQ34879258-03564CC1-B24E-4D78-83AC-F5E0863C516EQ34899949-AC593FEA-07E5-4D4A-BA4E-3BD35D11D9CCQ34968015-7EEA1C0A-B499-4311-B5F0-B033D3CC5369
P2860
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Use of comprehensive geriatric ...... of Geriatric Oncology (SIOG).
@ast
Use of comprehensive geriatric ...... of Geriatric Oncology (SIOG).
@en
type
label
Use of comprehensive geriatric ...... of Geriatric Oncology (SIOG).
@ast
Use of comprehensive geriatric ...... of Geriatric Oncology (SIOG).
@en
prefLabel
Use of comprehensive geriatric ...... of Geriatric Oncology (SIOG).
@ast
Use of comprehensive geriatric ...... of Geriatric Oncology (SIOG).
@en
P2093
P50
P1476
Use of comprehensive geriatric ...... y of Geriatric Oncology (SIOG)
@en
P2093
Harvey Jay Cohen
Jean-Pierre Droz
Lazzaro Repetto
Liv Sørbye
Martine Extermann
Matti Aapro
Task Force on CGA of the International Society of Geriatric Oncology
Vincent Mor
P304
P356
10.1016/J.CRITREVONC.2005.06.003
P577
2005-09-01T00:00:00Z